OneCell Diagnostics funding, investors and company details

OneCell Diagnostics is an emerging Healthcare startup from Mumbai, working in the space of Specializes in precision oncology through AI-powered liquid biopsy tests. Founded by Mohan Uttarwar.

Company: Onecell Diagnostics India Private Limited
Sector: Healthcare
Location: Mumbai
Founders: Mohan Uttarwar
Total funding raised: ₹135.3 Cr

Company overview

OneCell Diagnostics (now 1Cell.Ai) specializes in precision oncology through AI-powered liquid biopsy tests analyzing circulating tumor cells (CTCs) for multi-omics profiling. It offers products like OncoIndx for genomic testing, OncoDiscover for CTC detection, OncoMonitor for therapy monitoring, and OncoPredikt using AI to predict biomarkers from histopathology images at lower costs. The iCare platform aids clinicians in interpreting complex data, supporting cancer recurrence detection, treatment response, and clinical trials with enhanced accuracy over traditional methods.

Funding rounds

Latest round (Series A): $ 16.00 Mn (₹135.30 Cr.), 2024-11-21. Investors: Celesta Capital, Tenacity Ventures, Cedars Sinai, Eragon, Singularity Ventures